探索溶解曲线变异性来源的非线性混合效应建模与模拟:一个BCS II类案例示例

E. Karatza, V. Karalis
{"title":"探索溶解曲线变异性来源的非线性混合效应建模与模拟:一个BCS II类案例示例","authors":"E. Karatza, V. Karalis","doi":"10.35248/0975-0851.20.12.406","DOIUrl":null,"url":null,"abstract":"Purpose: Irbesartan is a BCS class II compound that exhibits pH– and buffer capacity–dependent dissolution behavior. The aim of this study was to apply non-linear mixed effects modelling on dissolution data of two immediate release products containing Irbesartan in order to characterize and quantify the sources of inter-dissolution profile variability. Methods: Nonlinear mixed effects modelling was applied to describe the dissolution curves obtained for Irbesartan in three different pH-value media (1.2, 4.5, 6.8) with two different products (reference product: Aprovel® and a generic test product). Simulations performed and the impact of inter-dissolution variability was assessed. Results: The % Irbesartan dissolved to time was found to follow a Weibull distribution. Τhe population scale parameter was estimated 0.252 and the shape parameter was estimated 0.706. The pH-value of the dissolution medium was found to significantly affect the scale parameter, while the formulation was found to affect the shape parameter. Simulations showed that probably some discrepancies in the in vivo performance of the two products can be expected. Conclusion: Through this case study the applicability and usefulness of nonlinear mixed effects modelling in oral drug formulation was highlighted and resides in its ability to identify and quantify sources of variability.","PeriodicalId":15184,"journal":{"name":"Journal of Bioequivalence & Bioavailability","volume":"60 1","pages":"1-6"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Non-linear Mixed Effects Modeling and Simulation for Exploring VariabilitySources in Dissolution Curves: A BCS Class II Case Example\",\"authors\":\"E. Karatza, V. Karalis\",\"doi\":\"10.35248/0975-0851.20.12.406\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: Irbesartan is a BCS class II compound that exhibits pH– and buffer capacity–dependent dissolution behavior. The aim of this study was to apply non-linear mixed effects modelling on dissolution data of two immediate release products containing Irbesartan in order to characterize and quantify the sources of inter-dissolution profile variability. Methods: Nonlinear mixed effects modelling was applied to describe the dissolution curves obtained for Irbesartan in three different pH-value media (1.2, 4.5, 6.8) with two different products (reference product: Aprovel® and a generic test product). Simulations performed and the impact of inter-dissolution variability was assessed. Results: The % Irbesartan dissolved to time was found to follow a Weibull distribution. Τhe population scale parameter was estimated 0.252 and the shape parameter was estimated 0.706. The pH-value of the dissolution medium was found to significantly affect the scale parameter, while the formulation was found to affect the shape parameter. Simulations showed that probably some discrepancies in the in vivo performance of the two products can be expected. Conclusion: Through this case study the applicability and usefulness of nonlinear mixed effects modelling in oral drug formulation was highlighted and resides in its ability to identify and quantify sources of variability.\",\"PeriodicalId\":15184,\"journal\":{\"name\":\"Journal of Bioequivalence & Bioavailability\",\"volume\":\"60 1\",\"pages\":\"1-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Bioequivalence & Bioavailability\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/0975-0851.20.12.406\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Bioequivalence & Bioavailability","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/0975-0851.20.12.406","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:厄贝沙坦是一种BCS II类化合物,具有pH和缓冲容量依赖的溶解行为。本研究的目的是对两种含厄贝沙坦的速释产品的溶出度数据应用非线性混合效应模型,以表征和量化内部溶出度变化的来源。方法:采用非线性混合效应模型描述厄贝沙坦在三种不同ph值介质(1.2、4.5、6.8)和两种不同产品(参考产品:阿普罗维尔®和通用测试产品)中的溶出曲线。进行了模拟并评估了溶解间变异性的影响。结果:厄贝沙坦随时间溶出的百分比服从威布尔分布。Τhe总体尺度参数估计为0.252,形状参数估计为0.706。发现溶解介质的ph值对粒径参数有显著影响,而配方对粒径参数有显著影响。模拟结果表明,这两种产品的体内性能可能存在一些差异。结论:通过本案例研究,强调了非线性混合效应模型在口服药物配方中的适用性和实用性,并指出其识别和量化变异性来源的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Non-linear Mixed Effects Modeling and Simulation for Exploring VariabilitySources in Dissolution Curves: A BCS Class II Case Example
Purpose: Irbesartan is a BCS class II compound that exhibits pH– and buffer capacity–dependent dissolution behavior. The aim of this study was to apply non-linear mixed effects modelling on dissolution data of two immediate release products containing Irbesartan in order to characterize and quantify the sources of inter-dissolution profile variability. Methods: Nonlinear mixed effects modelling was applied to describe the dissolution curves obtained for Irbesartan in three different pH-value media (1.2, 4.5, 6.8) with two different products (reference product: Aprovel® and a generic test product). Simulations performed and the impact of inter-dissolution variability was assessed. Results: The % Irbesartan dissolved to time was found to follow a Weibull distribution. Τhe population scale parameter was estimated 0.252 and the shape parameter was estimated 0.706. The pH-value of the dissolution medium was found to significantly affect the scale parameter, while the formulation was found to affect the shape parameter. Simulations showed that probably some discrepancies in the in vivo performance of the two products can be expected. Conclusion: Through this case study the applicability and usefulness of nonlinear mixed effects modelling in oral drug formulation was highlighted and resides in its ability to identify and quantify sources of variability.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信